Haralabos Papatheodorou English to Greek medical translator

  • Home
  • Greece
  • Athens
  • Haralabos Papatheodorou English to Greek medical translator

Haralabos Papatheodorou English to Greek medical translator English-to-Greek medical translation services for CROs, Pharma & MedTech. Specialized services by a board-certified Radiologist with 22+ years of experience.

Expert support for clinical trials, regulatory compliance, and MDR/IVDR technical documentation. 📣 Welcome to my about page!


📌 My name is Haralabos Papatheodorou, and I am a professional English into Greek medical translator with a strong medical background (MD, MSc, PhD, and Certified Radiologist) and a Certificate in Translation (meta|φραση Translator Training Center).


📌 I understand that

accurate communication is crucial in the medical field, and I am dedicated to ensuring that your clinical trial material, EMA documents, IVD manuals, and other material are translated with precision and attention to detail.


📌 I am familiar with the medical terminology, concepts, and procedures used in both English and Greek, and I can ensure that your translation is not only technically accurate but also clear and easy to understand.


📌 As a native Greek speaker, I have an in-depth understanding of the Greek language, its grammar, syntax, and nuances. I know how to adapt the language to the specific audience and purpose of the translation, whether it is for patients, healthcare professionals, or regulatory agencies.


📌 Contact me today to discuss your project, and I will provide you with a competitive quote and a personalized solution that meets your needs.


📧 [email protected]

-------------------------------

Επαγγελματικές υπηρεσίες μετάφρασης ιατρικών κειμένων | Αγγλικά > Ελληνικά | Ιατρός - Ακτινολόγος | Μέλος της Πανελλήνιας Ένωσης Μεταφραστών (ΠΕΜ) και της Mediterranean Editors & Translators (MET)

Lost in Translation: When Migrant Farm Workers Get Sick | The Hastings Center for BioethicsLanguage barriers in healthca...
08/06/2026

Lost in Translation: When Migrant Farm Workers Get Sick | The Hastings Center for Bioethics

Language barriers in healthcare directly compromise patient safety and clinical outcomes. This article from The Hastings Center highlights the severe consequences when vulnerable populations encounter systemic communication gaps during medical crises.

"The failure to guarantee professional medical interpretation for migrant farm workers violates basic ethical principles and fundamental human rights."

"As a result, workers’ employers often serve as translators. But this arrangement is ethically fraught. [...] Patients’ coworkers often serve as translators, as well. But their English skills and medical literacy are also often extremely limited, and they might have their own reasons to omit or downplay certain symptoms or other information."

The link to the full article is in the comment section below.

Photo by Tim Mossholder on Unsplash

-----------------

Supporting healthcare and life sciences teams with accurate medical translations that safeguard patient safety. Native Greek speaker with deep healthcare expertise.

DM for project inquiries.

For specialized clinical trial translations across multiple language pairs, visit Medical Translation Experts for CROs - MTEC. MTEC offers access to multiple specialized medical translators handling diverse language combinations for global trials.

From Deskilling and Mis-skilling to Never-skillingA recent Nature Medicine article titled "AI-induced never-skilling in ...
24/05/2026

From Deskilling and Mis-skilling to Never-skilling

A recent Nature Medicine article titled "AI-induced never-skilling in medical education" (link in the comments) outlines a concept we need to talk about in the language services industry.

"Never-skilling" happens when a professional offloads core cognitive tasks to AI from the very beginning of their career, meaning the foundational skills required to evaluate and critique complex data are never truly built ("trainees who rely on AI during the early formative years of clinical education may fail to develop the foundational reasoning skills that safe, independent practice requires").

In medical translation, we are entering a tricky phase. AI-enhanced translation tools generate outputs that are beautifully polished, syntactically flawless, and highly persuasive. But as anyone with a medical background knows, fluency does not equal clinical accuracy.

The immediate risk for the near future isn't that AI will make obvious, glaring errors. The real danger lies in what happens when we face a severe shortage of specialized medical translators who possess the deep clinical and academic training required to spot the hidden flaws.

For instance, AI models train on historical data. Without domain experts to catch and correct subtle algorithmic biases or outdated terminology, these biases become permanently baked into localized patient-facing materials and clinical documentation.

If the text reads perfectly, a generalist or non-specialized reviewer is highly likely to skim past profound clinical inaccuracies. You cannot correct a medical error in a translation if you don't have the clinical training to realize an error has been made.

AI is an efficiency partner, but it is not an authority. To protect patient safety and ensure the integrity of clinical data, we must actively combat "never-skilling." We need to continue training specialized medical translators in the "hard way" first (developing deep clinical reasoning, terminology management, and source-text skepticism) so they can effectively police the highly polished output of tomorrow's AI.

------------

Delivering regulatory-compliant translations for CROs, pharma companies, and medical device manufacturers. Native Greek speaker with deep healthcare expertise.

DM for project inquiries.

For specialized clinical trial translations across multiple language pairs, visit Medical Translation Experts for CROs - MTEC. MTEC offers access to multiple specialized medical translators handling diverse language combinations for global trials.

#ΤΝ

Is your Greek medical device documentation MDR-compliant, or just "translated"?The latest Team-NB Position Paper (v4) ma...
05/05/2026

Is your Greek medical device documentation MDR-compliant, or just "translated"?

The latest Team-NB Position Paper (v4) makes one thing clear: Technical Documentation for the Greek market requires more than linguistic fluency. It requires clinical and regulatory alignment.

For CROs and MedTech manufacturers, the Greek National Organisation for Medicines (ΕΟΦ) has specific expectations for professional-use devices and patient-facing materials.

Under the MDR, "close enough" is a regulatory risk.

Ensuring that Greek documentation aligns with the latest European Notified Body standards is essential for maintaining market access.

You can find the full analysis of the Team-NB v4 requirements and how they impact the Greek market in the link below (check the first comment for the link).

New Regulatory Requirements: Is Your Greek SmPC Compliant with QRD Version 7?The EMA has recently updated the QRD Append...
04/05/2026

New Regulatory Requirements: Is Your Greek SmPC Compliant with QRD Version 7?

The EMA has recently updated the QRD Appendix II (version 7), bringing significant changes to how MedDRA terminology and System Organ Classes (SOC) must be handled in Section 4.8 of the SmPC.

For Regulatory Affairs teams and Pharmaceutical manufacturers, this is a technical requirement that directly impacts ePI (electronic Product Information) validation and approval timelines.

For the full breakdown of the version 7, check link in comments.

In the era of digital compliance, a Greek SmPC functions as a dataset. Precision in medical translation ensures that your product's clinical science is preserved and your time-to-market is protected.

-----------------------

Delivering regulatory-compliant translations for CROs, pharma companies, and medical device manufacturers. Native Greek speaker with deep healthcare expertise.

DM for project inquiries.

For specialized clinical trial translations across multiple language pairs, visit Medical Translation Experts for CROs - MTEC. MTEC offers access to multiple specialized medical translators handling diverse language combinations for global trials.

A recent editorial in Nature Medicine highlighted several critical points regarding the early adoption of AI-enhanced te...
27/04/2026

A recent editorial in Nature Medicine highlighted several critical points regarding the early adoption of AI-enhanced technologies in healthcare.

It is worth reflecting on the potential consequences of the premature and unregulated use of AI-driven translation and interpretation tools healthcare settings—whether standalone or integrated into medical devices.

Specifically, what are the associated risks, and does a significant regulatory gap exist?

Furthermore, should these tools be classified and regulated as Software as a Medical Device (SaMD) / Medical Device Software (MDSW), despite their current status?

Nature Portfolio

How an eye physician who translated classical Greek medicine into Arabic helped form Western medical thought: On Hunayn ...
07/04/2026

How an eye physician who translated classical Greek medicine into Arabic helped form Western medical thought: On Hunayn bin Isḥāq al-Abbadi (d. 873 AD), translation, and medical terminology

"Hunayn ibn isḥāq [...] adopted a translation of the text’s full meaning, moving away from the literal translation that was then common."

"Initially, Hunayn translated Greek books into syriac—his mother tongue—before delegating the task of translating them from syriac to arabic to other translators. This approach had a positive impacton the flourishing and expansion of the translation movement, especially since the number of translators proficient in Greek was limited compared to those skilled in syriac."

"Moreover, Hunayn ibnisḥāq played a pivotal role in enriching the arabic language with new terms, such as retina and cornea,particularly in ophthalmology. He achieved this by employing descriptive techniques and analogies toarabize terms, often incorporating metaphors and avoiding mere literal translation. this approach greatlyfacilitated the precise rendering of scientific terminology"



Al-Zubi, D. H. et al. (2025) ‘Translation and ophthalmology during the Abbasid Era: Hunayn bin Isḥāq’s ‘In the Eye, Two Hundred and Seven Issues’ as a model of medical scholarship’, Cogent Arts & Humanities, 12(1). doi: 10.1080/23311983.2025.2522116.

Clinical trials regulation (EU) no 536/2014 | Questions & answers v. 7.2 (27.3.2026)79. Any translation of the patient f...
28/03/2026

Clinical trials regulation (EU) no 536/2014 | Questions & answers v. 7.2 (27.3.2026)

79. Any translation of the patient facing documents will need to be submitted in Part II in line with Annex II of this document (i.e., for several Member States patient facing documents should be provided to the CT participants in a language understandable for the CT participants). Sponsors are responsible for ensuring the quality of the texts to be provided to the participants.

80. There is currently no legal basis in the CTR to request the submission of all patient facing documents in the part II documentation package and/or to March 2026 Page 29 of 161 require their translation.

109. In case, when documents are missing or incorrect (e.g. because they contain nonsensical information or information in a wrong language making the review impossible), the “Request for additional information” process will be used to request the sponsor to submit the necessary documents and information. This implies that the RMS (in case of missing translations of part I documents (art. 14(6), in line with article 26 of the CTR) or the Member State to be added (for missing part II documents (art 14(8)) asks the sponsor to reply within a very short period of time to be set by the Member State.

140. A Part I SM cannot be submitted if there is an ongoing assessment in a different Member State concerned for an additional Member State concerned (Article 14), since this procedure also involves changes in the Part I dossier (translations).

272. Summary of Results: The Summary of results is expected to be submitted in English and no translations are required.

492.The full inspection report must be submitted in CTIS in its original language. Member States may request a translation of either the full report or a summary of key findings, depending on their needs.

For : "The following items may be provided in EN alone on the first day (D0) of each CTIS submission: Cover letter, Protocol and Application form. However, EL translations will be requested during Validation/Assessment."

In case of mononational clinical trials one of the national language(-s) is acceptable. When a clinical trial expands beyond the country, the sponsor should provide the translation in EN of the documents as outlined in Annex II.

------

Delivering regulatory-compliant translations for CROs, pharma companies, and medical device manufacturers. Native Greek speaker with deep healthcare expertise.

DM for project inquiries.

For specialized clinical trial translations across multiple language pairs, visit Medical Translation Experts for CROs - MTEC. MTEC offers access to multiple specialized medical translators handling diverse language combinations for global trials.



European Commission European Medicines Agency

Artificial intelligence translation in healthcare: an urgent call for evidence-informed policy frameworks | BMJ Health &...
18/03/2026

Artificial intelligence translation in healthcare: an urgent call for evidence-informed policy frameworks | BMJ Health & Care Informatics


“The rapid emergence of artificial intelligence (AI) translation tools has accelerated well beyond the capacity of our current regulatory infrastructure, creating a profound and urgent crisis at the intersection of technological innovation and healthcare equity. “

“The legal frameworks governing language access, established decades before the advent of large language models (LLMs), have created a policy vacuum where technological adoption is surging while regulatory adaptation lags dangerously behind.”

Language barriers remain a persistent and dangerous obstacle to safe healthcare. Studies findings on patients with limited English proficiency (LEP):

· systematically worse outcomes than their English-speaking counterparts,

· higher rates of adverse events involving physical harm,

· increased odds of 30-day hospital readmissions,

· higher rates of avoidable emergency department revisit,

· adverse events were nearly twice as likely to result in physical harm compared with English-speaking patients, often due to errors in communication,

· language discordance is associated with lower patient satisfaction and a higher risk of medication errors.

“AI-powered translation tools offer the promise of an immediate, scalable and low-cost solution to these delays. Yet, this technological promise is shadowed by an emerging reality: the performance of these tools is not uniform. “

“The quality of AI-generated medical translations varies dramatically depending on the volume of training data available for the target language. This ‘resource gap’ results in superior performance for languages with abundant online text, while performance degrades precipitously for digitally underrepresented languages. “

“Without immediate policy intervention, we risk cementing a two-tier healthcare system where speakers of widely used languages benefit from cutting-edge AI assistance, while speakers of less common languages are exposed to disproportionate medical errors.”

---------------

Delivering regulatory-compliant translations for CROs, pharma companies, and medical device manufacturers. Native Greek speaker with deep healthcare expertise.

DM for project inquiries.

For specialized clinical trial translations across multiple language pairs, visit Translation Experts for CROs - MTEC. MTEC offers access to multiple specialized medical translators handling diverse language combinations for global trials.

Αλφαβητάρι ΥγείαςΤο Αλφαβητάρι Υγείας είναι μια ψηφιακή πλατφόρμα ενημέρωσης και εκπαίδευσης που δημιουργήθηκε από την Έ...
31/01/2026

Αλφαβητάρι Υγείας

Το Αλφαβητάρι Υγείας είναι μια ψηφιακή πλατφόρμα ενημέρωσης και εκπαίδευσης που δημιουργήθηκε από την Ένωση Ασθενών Ελλάδας.

Σκόπος της είναι να κάνει την πληροφορία για την Υγεία πιο κατανοητή, αξιόπιστη και προσβάσιμη σε όλους.

Περιλαμβάνει, μεταξύ άλλων, δίγλωσσο ευρετήριο ιατρικών όρων (Αγγλικα - Ελληνικά) και την κωδικοποίηση νόσων κατά ICD-10.

#ΑπλήΓλώσσα

Decision on how the European Parliament assessed whether prices offered in two tenders for the provision of translation ...
29/11/2025

Decision on how the European Parliament assessed whether prices offered in two tenders for the provision of translation services were abnormally low (case 2058/2024/VB) | European Ombudsman

An interesting case that gives insights on EU translation services tenders.

"The complainant argued that the Parliament had failed to analyse whether the prices offered by the first two ranked tenderers were abnormally low."

"The first-ranked tenderer, which had tendered a price of EUR 9 per page and received a quality score of 91, scored 127,5 points. The second-ranked tenderer, which had tendered a price of EUR 11,90 per page and received a quality score of 80,2, scored 88,32 points. The complainant, which had tendered a price of EUR 22,08 per page and received a quality score of 86,5, scored 86,63 points."

"On 5 November 2024, the complainant asked the Parliament if it had considered the prices tendered by the first two tenderers as ‘abnormally low’ under the EU Financial Regulation,[5] and whether it had requested clarifications from them on this matter."

"The Parliament’s Directorate-General for Translation, which was the contracting authority in this case, applies a mathematical criterion to detect tenders that appear abnormally low: a tender would appear to be abnormally low when the tendered price is at least 40% lower than the arithmetical mean of all prices tendered per lot. This is allowed under EU law.[13] In this case, the application of this criterion did not indicate that the prices tendered would appear abnormally low.[14]"

"In addition, the tenderers had provided a declaration of each translator stating that they were willing to work with the tenderer if it was awarded the contract. The translators were thus necessarily aware of the conditions under which they would be remunerated, and the Parliament had no reason to question the veracity of the declarations."

" It considered the complainant’s argument about the minimum wage in Poland to be unfounded. The complainant had not defined the reference rate used in its reasoning, nor explained how the price per page would relate to the cost per hour. In any case, the Parliament noted that, when the tenders were assessed, the price of the first two tenderers were higher than the minimum hourly rate for contracts other than employment contracts[17] and of the minimum monthly wage per hour in Poland.[18]"

" Only when the pre-translated parts exceed 81% of the document to be translated is the price reduced under the contract.[20] There might thus be cases in which translators are paid fully even if they have to translate 20% of a document and only proofread the rest."



FIT Europe Πανελλήνια Ένωση Επαγγελματιών Μεταφραστών Πτυχιούχων ΙΠ - Peempip Πανελλήνια Ένωση Mεταφραστών - ΠΕΜ

Address

Athens

Alerts

Be the first to know and let us send you an email when Haralabos Papatheodorou English to Greek medical translator posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share